Treat-to-target in axial spondyloarthritis: an observational study in daily practice (2022)
https://pubmed.ncbi.nlm.nih.gov/34175950/

How is early spondyloarthritis defined in the literature? Results from a systematic review (2022)
https://pubmed.ncbi.nlm.nih.gov/35667332/

Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial (2021)
https://pubmed.ncbi.nlm.nih.gov/33958325/

Progression from subclinical inflammation to overt SpA in first degree relatives of SpA patients is associated with HLA-B27: the Pre-SpA cohort (2021)
https://pubmed.ncbi.nlm.nih.gov/34219406/

Development and validation of an alternative ankylosing spondylitis disease activity score when patient global assessment is unavailable (2021)
https://pubmed.ncbi.nlm.nih.gov/32572483/

Infliximab treatment reduces depressive symptoms in patients with ankylosing spondylitis: an ancillary study to a randomized controlled trial (ASSERT) (2020)
https://pubmed.ncbi.nlm.nih.gov/32993799/

Validation and implementation of a patient-reported experience measure for patients with rheumatoid arthritis and spondyloarthritis in the Netherlands (2020)
https://pubmed.ncbi.nlm.nih.gov/32318970/

Validation of the self-administered comorbidity questionnaire adjusted for spondyloarthritis: results from the ASAS-COMOSPA study (2020)
https://pubmed.ncbi.nlm.nih.gov/31665462/

Development of ASAS quality standards to improve the quality of health and care services for patients with axial spondyloarthritis (2020)
https://pubmed.ncbi.nlm.nih.gov/31604704/